Patents by Inventor Susan K. Paulson

Susan K. Paulson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120225080
    Abstract: The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: January 13, 2012
    Publication date: September 6, 2012
    Applicant: Abbott Laboratories
    Inventors: Matthew W. Hruska, Susan K. Paulson, Walid Awni, Peter Noertersheuser, Sven Mensing
  • Publication number: 20120219562
    Abstract: The invention provides a method of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: March 8, 2012
    Publication date: August 30, 2012
    Applicant: Abbott Laboratories
    Inventors: Joaquin Mario Valdes, Susan K. Paulson
  • Publication number: 20120189637
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: October 6, 2011
    Publication date: July 26, 2012
    Inventors: Joaquin Mario Valdes, Susan K. Paulson, Elliot K. Chartash, Yanjun Bao, Parvez M . Mulani, Murali Sundaram, Yihua Gu, Michele Olds Heckaman, Tom C. Harris, Martin Kaul, David Allen Williams, Richard G.B. Langley, Kenneth Gordon
  • Patent number: 8178092
    Abstract: The invention provides a method of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: May 15, 2012
    Assignee: Abbott Laboratories
    Inventors: Joaquin Mario Valdes, Susan K. Paulson
  • Publication number: 20110206680
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 25, 2011
    Applicants: ABBOTT LABORATORIES, ABBOTT GMBH & CO., KG
    Inventors: JOAQUIN MARIO VALDES, ELLIOT K. CHARTASH, WILLIAM T. BARCHUK, SUSAN K. PAULSON, KENNETH B. GORDON, WALID M. AWNI, YANJUN BAO, WILLIAM G. GLASS, YIHUA GU, TOM C. HARRIS, MARTIN KAUL, PARVEZ M. MULANI, PETER NOERTERSHEUSER, MARTIN M. OKUM
  • Publication number: 20100297143
    Abstract: The invention provides a method of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: June 10, 2010
    Publication date: November 25, 2010
    Applicant: Abbott Laboratories
    Inventors: Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Joaquin M. Valdes, Alexandra B. Kimball
  • Patent number: 7776331
    Abstract: The invention provides a method of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Grant
    Filed: January 16, 2008
    Date of Patent: August 17, 2010
    Assignee: Abbott Laboratories
    Inventors: Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Joaquin M. Valdes, Alexandra B. Kimball
  • Publication number: 20100028363
    Abstract: The invention provides a method of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: March 11, 2009
    Publication date: February 4, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Joaquin Mario VALDES, Susan K. PAULSON
  • Publication number: 20090317399
    Abstract: The invention provides methods, uses and compositions for the treatment of Crohn's disease. The invention describes methods and uses for treating Crohn's disease, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to induce and maintain remission of Crohn's disease in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of Crohn's disease in a subject.
    Type: Application
    Filed: May 18, 2007
    Publication date: December 24, 2009
    Inventors: Paul F. Pollack, Rebecca S. Hoffman, Cheryl L. Renz, Susan K. Paulson, Zhuoying Peng, William J. Sandborn, Stephen B. Hanauer, Paul Rutgeerts
  • Publication number: 20090304682
    Abstract: Multiple-variable dose methods for treating TNF?-related disorders, including Crohn's disease and psoriasis, comprising administering TNF? inhibitors, including TNF? antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
    Type: Application
    Filed: January 7, 2008
    Publication date: December 10, 2009
    Inventors: Rebecca S. Hoffman, Elliot K. Chartash, Lori K. Taylor, George R. Granneman, Philip Yan, Susan K. Paulson, Joanna Z. Peng
  • Publication number: 20090258018
    Abstract: The invention provides methods and compositions for the treatment of juvenile idiopathic arthritis (JIA) where a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat JIA. In particular, the invention is directed to methods and compositions relating to a fixed dosing regimen for treating JIA with a TNF? inhibitor.
    Type: Application
    Filed: June 10, 2008
    Publication date: October 15, 2009
    Inventors: John R. Medich, Susan K. Paulson, Peter A. Noertersheuser